Antidiabetic effect and mode of action of cytopiloyne

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Chang, Cicero Lee Tian ^a   Liu, Hsien Yueh ^a   Kuo, Tien Fen ^b   Hsu, Yi Jou ^b   Shen, Ming Yi ^c   Pan, Chien Yuan ^d   Yang, Wen Chin ^a,b,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CALCIUM; CYTOPILOYNE; DIACYLGLYCEROL; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; LONG TERM CARE; MALE; MOLECULAR MECHANICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE DRUG DOSE; STREPTOZOCIN DIABETES; THERAPY EFFECT;

EID: 84876531867     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/685642     Document Type: Article

References (37)

1. Wicksteed B., Alarcon C., Briaud I., Lingohr M. K., Rhodes C. J., Glucose-induced translational control of proinsulin biosynthesis is proportional to preproinsulin mRNA levels in islet β -cells but not regulated via a positive feedback of secreted insulin. Journal of Biological Chemistry 2003 278 43 42080 42090 2-s2.0-0142149134 10.1074/jbc.M303509200 (Pubitemid 37310474)
2. Newsholme P., Gaudel C., McClenaghan N. H., Nutrient regulation of insulin secretion and β -cell functional integrity. Advances in Experimental Medicine and Biology 2010 654 91 114 2-s2.0-77953955152 10.1007/978-90-481-3271-3-6
3. Laakso M., Insulin resistance and its impact on the approach to therapy of type 2 diabetes. International Journal of Clinical Practice, Supplement 2001 121 8 12 2-s2.0-0034804703 (Pubitemid 32916690)
4. Clements R. S., Bell D. S. H., Complications of diabetes: prevalence, detection, current treatment, and prognosis. American Journal of Medicine 1985 79 5 2 7 2-s2.0-0022380838 (Pubitemid 16213221)
5. Boyle J. P., Engelgau M. M., Thompson T. J., Goldschmid M. G., Beckles G. L., Timberlake D. S., Herman W. H., Ziemer D. C., Gallina D. L., Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitus. American Journal of Epidemiology 1999 149 1 55 63 2-s2.0-0032962002 (Pubitemid 29028862)
6. Attele A. S., Zhou Y. P., Xie J. T., Wu J. A., Zhang L., Dey L., Pugh W., Rue P. A., Polonsky K. S., Yuan C. S., Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002 51 6 1851 1858 2-s2.0-0036266324 (Pubitemid 34564298)
7. Krentz A. J., Bailey C. J., Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs 2005 65 3 385 411 2-s2.0-13644263258 10.2165/00003495-200565030-00005 (Pubitemid 40227460)
8. Howlett H. C. S., Bailey C. J., A risk-benefit assessment of metformin in type 2 diabetes mellitus. Drug Safety 1999 20 6 489 503 2-s2.0-0032985166 10.2165/00002018-199920060-00003 (Pubitemid 29296595)
9. Purnell J. Q., Weyer C., Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity. Treatments in Endocrinology 2003 2 1 33 47 2-s2.0-0042861368 10.2165/00024677-200302010-00004 (Pubitemid 37051601)
10. Egan J. M., Bulotta A., Hui H., Perfetti R., GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes/Metabolism Research and Reviews 2003 19 2 115 123 2-s2.0-0037357951 10.1002/dmrr.357 (Pubitemid 36417195)
11. Marles R. J., Farnsworth N. R., Antidiabetic plants and their active constituents. Phytomedicine 1995 2 2 137 189 2-s2.0-0028835878
12. Habeck M., Diabetes treatments get sweet help from nature. Nature Medicine 2003 9 10 1228 2-s2.0-0142073834 (Pubitemid 37279826)
13. Oubré A. Y., Carlson T. J., King S. R., Reaven G. M., From plant to patient: an ethnomedical approach to the identification of new drugs for the treatment of NIDDM. Diabetologia 1997 40 5 614 617 2-s2.0-0030903290 10.1007/s001250050724 (Pubitemid 27186801)
14. Alarcon-Aguilar F. J., Roman-Ramos R., Flores-Saenz J. L., Aguirre-Garcia F., Investigation on the hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and alloxan-diabetic mice. Phytotherapy Research 2002 16 4 383 386 2-s2.0-0036292507 10.1002/ptr.914 (Pubitemid 34700279)
15. Lin C. C., Crude drugs used for the treatment of diabetes mellitus in Taiwan. American Journal of Chinese Medicine 1992 20 3-4 269 279 2-s2.0-0027030580
16. Ubillas R. P., Mendez C. D., Jolad S. D., Luo J., King S. R., Carlson T. J., Fort D. M., Antihyperglycemic acetylenic glucosides from Bidens pilosa. Planta Medica 2000 66 1 82 83 2-s2.0-0033974926 (Pubitemid 30097291)
17. Chang S. L., Chang C. L. T., Chiang Y. M., Hsieh R. H., Tzeng C. R., Wu T. K., Sytwu H. K., Shyur L. F., Yang W. C., Polyacetylenic compounds and butanol fraction from Bidens pilosa can modulate the differentiation of helper T cells and prevent autoimmune diabetes in non-obese diabetic mice. Planta Medica 2004 70 11 1045 1051 2-s2.0-9744246006 10.1055/s-2004-832645 (Pubitemid 39587038)
18. Chang C. L. T., Chang S. L., Lee Y. M., Chiang Y. M., Chuang D. Y., Kuo H. K., Yang W. C., Cytopiloyne, a polyacetylenic glucoside, prevents type 1 diabetes in nonobese diabetic mice. Journal of Immunology 2007 178 11 6984 6993 2-s2.0-34249784226
19. Chien S. C., Young P. H., Hsu Y. J., Chen C. H., Tien Y. J., Shiu S. Y., Li T. H., Yang C. W., Marimuthu P., Tsai L. F. L., Yang W. C., Anti-diabetic properties of three common Bidens pilosa variants in Taiwan. Phytochemistry 2009 70 10 1246 1254 2-s2.0-69249156977 10.1016/j.phytochem.2009.07.011
20. Hsu Y. J., Lee T. H., Chang C. L. T., Huang Y. T., Yang W. C., Anti-hyperglycemic effects and mechanism of Bidens pilosa water extract. Journal of Ethnopharmacology 2009 122 2 379 383 2-s2.0-60849088848 10.1016/j.jep.2008. 12.027
21. Harrity T., Farrelly D., Tieman A., Chu C., Kunselman L., Gu L., Ponticiello R., Cap M., Qu F., Shao C., Wang W., Zhang H., Fenderson W., Chen S., Devasthale P., Jeon Y., Seethala R., Yang W. P., Ren J., Zhou M., Ryono D., Biller S., Mookhtiar K. A., Wetterau J., Gregg R., Cheng P. T., Hariharan N., Muraglitazar, a novel dual (α / γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β -cell function in db/db mice. Diabetes 2006 55 1 240 248 2-s2.0-33644783769 10.2337/diabetes.55.1.240 (Pubitemid 43343321)
22. Cardinal J. W., Allan D. J., Cameron D. P., Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced β cell death in inbred mice. Endocrinology 1998 139 6 2885 2891 2-s2.0-0031730598 10.1210/en.139.6.2885 (Pubitemid 28512400)
23. Surwit R. S., Seldin M. F., Kuhn C. M., Cochrane C., Feinglos M. N., Control of expression of insulin resistance and hyperglycemia by different genetic factors in diabetic C57BL/6J mice. Diabetes 1991 40 1 82 87 2-s2.0-0026025628
24. Cefalu W. T., Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. ILAR Journal 2006 47 3 186 198 2-s2.0-33745595310 (Pubitemid 43986028)
25. Miwa I., Ichimura N., Sugiura M., Hamada Y., Taniguchi S., Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 2000 141 8 2767 2772 2-s2.0-0034464215 10.1210/en.141.8.2767 (Pubitemid 32250437)
26. Sung H. H., Juang J. H., Lin Y. C., Kuo C. H., Hung J. T., Chen A., Chang D. M., Chang S. Y., Hsieh S. L., Sytwu H. K., Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. Journal of Experimental Medicine 2004 199 8 1143 1151 2-s2.0-2442536706 10.1084/jem.20031939 (Pubitemid 38619910)
27. Bligh E. G., Dyer W. J., A rapid method of total lipid extraction and purification. Canadian Journal of Biochemistry and Physiology 1959 37 8 911 917 2-s2.0-33845261493
28. Garris D. R., Garris B. L., Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia. Cell and Tissue Research 2005 319 2 231 242 2-s2.0-12944327383 10.1007/s00441-004-1019-y (Pubitemid 40174517)
29. Leiter E. H., Lee C. H., Mouse models and the genetics of diabetes: is there evidence for genetic overlap between type 1 and type 2 diabetes? Diabetes 2005 54 2 S151 S158 2-s2.0-33644778787 10.2337/diabetes.54.suppl-2.S151 (Pubitemid 43343342)
30. Yamanaka M., Itakura Y., Tsuchida A., Nakagawa T., Taiji M., Brain-derived neurotrophic factor (BDNF) prevents the development of diabetes in prediabetic mice. Biomedical Research 2008 29 3 147 153 2-s2.0-48249087344 10.2220/biomedres.29.147
31. Howell S. L., Jones P. M., Persaud S. J., Protein kinase C and the regulation of insulin secretion. Biochemical Society Transactions 1990 18 1 114 116 2-s2.0-0025174139 (Pubitemid 20048500)
32. Howell S. L., Jones P. M., Persand S. J., Regulation of insulin secretion: the role of second messengers. Diabetologia 1994 37 2 S30 S35 2-s2.0-0027933317 (Pubitemid 24288789)
33. Jones P. M., Persaud S. J., Howell S. L., Protein kinase C and the regulation of insulin secretion from pancreatic B cells. Journal of Molecular Endocrinology 1991 6 2 121 127 2-s2.0-0026034689
34. Persaud S. J., Jones P. M., Sugden D., Howell S. L., Translocation of protein kinase C in rat islets of Langerhans. Effects of a phorbol ester, carbachol and glucose. FEBS Letters 1989 245 1-2 80 84 2-s2.0-0024520472 10.1016/0014-5793(89)80196-6 (Pubitemid 19076207)
35. Straub S. G., Sharp G. W. G., Glucose-stimulated signaling pathways in biphasic insulin secretion. Diabetes/Metabolism Research and Reviews 2002 18 6 451 463 2-s2.0-0036868797 10.1002/dmrr.329 (Pubitemid 36041600)
36. Ohneda K., Ee H., German M., Regulation of insulin gene transcription. Seminars in Cell and Developmental Biology 2000 11 4 227 233 2-s2.0-0034507714 10.1006/scdb.2000.0171 (Pubitemid 32066129)
37. Alarcon C., Wicksteed B., Rhodes C. J., Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level. Diabetologia 2006 49 12 2920 2929 2-s2.0-33750914846 10.1007/s00125-006-0433-y (Pubitemid 44730295)